Search results
Results from the Health.Zone Content Network
Executive Order 13987, officially titled Organizing and Mobilizing the United States Government to Provide a Unified and Effective Response to Combat COVID-19 and to Provide United States Leadership on Global Health and Security, is the third executive order signed by the U.S. President Joe Biden on January 20, 2021. The order indicates that ...
The White House COVID-19 Response Team was the task force during the presidency of Joe Biden to respond to the COVID-19 pandemic in the United States. It was set up by Joe Biden on his first day in office [1] – January 20, 2021 – and replaced President Trump 's White House Coronavirus Task Force and Joe Biden 's transitional COVID-19 ...
The American Rescue Plan Act of 2021, also called the COVID-19 Stimulus Package or American Rescue Plan, is a US$1.9 trillion economic stimulus bill passed by the 117th United States Congress and signed into law by President Joe Biden on March 11, 2021, to speed up the country's recovery from the economic and health effects of the COVID-19 pandemic and recession.
On Monday, HHS announced the formation of the Office of Long COVID Research and Practice to lead the federal government’s response to long Covid, a sometimes-debilitating condition marked by ...
The US government has awarded more than $1.4 billion to kick-start the development of new vaccines and therapies to fight Covid-19, the US Department of Health and Human Services announced Tuesday.
Medscape Education Awarded Health and Human Services (HHS) Contract to Support Clinicians’ Use of Telemedicine During COVID‐19 Pandemic . Increased reliance on virtual care platforms by health ...
More than 7 million Americans have received the updated COVID-19 vaccine since it was approved one month ago, according to the Department of Health and Human Services (HHS). The Food and Drug ...
On March 30, HHS announced the first grant to a vaccine in development with $456 million allocated to Johnson & Johnson. Additional funds were approved for Moderna, AstraZeneca, Regeneron, Novavax, Pfizer, and a partnership between Sanofi and GlaxoSmithKline. The program's timeline was formally announced on May 15.